Skip to content

Superficial Cervical Plexus Block for Postoperative Chronic Pain

CompletedNot applicableNCT05108337
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The incidence of postoperative chronic pain after craniotomy is high. Postoperative chronic pain seriously affects patient's quality of life. Compound local scalp nerve block is a good choice for analgesia after craniotomy. However, the scalp nerve block commonly cannot cover the area of suboccipital retrosigmoid approach craniotomy, leading to incomplete block. Superficial cervical plexus block (SCPB) is theoretically promising to solve the analgesia requirements of such surgical approach. At the same time, ultrasound guidance can not only accurately locate, ensure the effect of block and avoid accidental injury during puncture. The purpose of this study is to explore whether ultrasound-guided superficial cervical plexus block can safely and effectively reduce the incidence of chronic pain after craniotomy via suboccipital retrosigmoid approach.

Study details

Official title
Ultrasound Guided Superficial Cervical Plexus Block for Chronic Pain After Craniotomy Via Suboccipital Retrosigmoid Approach: A Randomized Controlled Trial
Conditions
  • Neurosurgery
Interventions
Sponsor
Beijing Tiantan Hospital
Start date
2021-11-04
Primary completion
2023-11-22
Sex
All
Age range
from 18 Years to 65 Years
Healthy volunteers
true
Results posted
No results posted in this snapshot
Countries
China
Total sites listed
2

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Elective suboccipital retrosigmoid approach approach craniotomy; 2. Age between 18 and 65 years; 3. American Society of Anesthesiologists (ASA) physical status I-III. Exclusion Criteria: 1. The patients or legal clients refuse to provide informed consent; 2. Local infection; 3. Preoperative impairment of consciousness and cognitive function; 4. Uncontrolled hypertension; 5. Inability to communicate; 6. Allergies to experimental drugs; 7. History of drug abuse; 8. History of chronic headache; 9. Aphasia and hearing impairment; 10. Patients undergoing second craniotomy; 11. Body mass index \< 18.5 kg/m2 or \> 35.0 kg/m2;

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05108337